Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 4 Study of Sinovac's Varicella Vaccine (Provarix) in Zhejiang
NCT05460429Phase 4Unknown
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Jul 2022
- Primary completion
- Mar 2023
- Countries
- 1
01
Overview
A Phase 4 trial of varicella virus vaccine live in varicella (VZV), sponsored by Sinovac Biotech Ltd.. Status: unknown.
02
Drugs
varicella virus vaccine live
03
Conditions
varicella (VZV)
Beyond the preview
Go deeper on NCT05460429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05460429.